Biotech News
-
XPhyto Announces Psychedelic Pharmaceutical Production Agreement
February 3, 2021 (Source) — XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that XPhyto Laboratories…
-
Sixth Wave Updates on AMIPs Technology for Rapid Detection of Viruses & Mutations
February 2, 2021 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: ATURF) (FSE: AHUH) (“Sixth Wave”, or the…
-
Perimeter Medical Imaging AI Announces Acceleration of Expiry Date of Warrants
February 1, 2021 (Source) — Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology…
-
Predictmedix Announces Results of its Annual and Special Meeting of Shareholders
February 1, 2021 (Source) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce the results…
-
DIAGNOS announces the re-opening of its medical testing in Panama
January 28, 2021 (Source) — Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader…
-
Hemostemix Announces HS 12 – 01 Clinical Trial Completion of Subjects’ Follow-Up Visits at the End of March and Warrants Extended and Repriced
January 28, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (“Hemostemix” or the “Company”) is pleased to…
-
XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact
January 28, 2021 (Source) — Construction of commercial drug manufacturing facility in Germany Four clinical studies in neurological…
-
Predictmedix Inc. – Corporate Update
January 25, 2021 (Source) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to provide a corporate update…
-
Valeo Pharma’s Redesca™ Receives Positive Recommendation for Public Reimbursement in Quebec
January 25, 2021 (Source) — Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”),…
-
XPhyto Provides Comments on Promotional and Marketing Activity
January 22, 2021 (Source) — XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Corporation”) at the request of OTC Markets, is providing…
